Immunofluorescence staining revealed increased levels of ZO-1 and claudin-5 following cerebral ischemia in the Weisheng-tang-treated group, suggesting that Weisheng-tang reduces the degree of BBB disruption by increasing the levels of ZO-1 and claudin-5. The gene discussed is CLDN5; the disease is Cerebral ischemia.